Video summary

Аденома простаты, новые способы уменьшения железы. Обзор недостатков и преимуществ всех методов

Main summary

Key takeaways

Educational

Main ideas / lessons

  • Purpose of the talk: The speaker explains non-radical / minimally invasive ways to reduce prostate enlargement (BPH/“adenoma”) and improve urinary symptoms, with a focus on maintaining sexual function for men who are sexually active.

  • Why it’s needed: With age, prostate size increases and can worsen quality of life and urinary symptoms, such as:

    • frequent urination
    • nighttime urination
    • weak urine stream
    • difficult urination

  • Problem with “information overload”: Online marketing and clinic websites often highlight only advantages, making it hard for patients to choose a method.

  • Treatment philosophy: “Gentle” methods aim to improve symptoms without radical tissue removal, but may have:

    • temporary effects, and/or
    • a higher chance of recurrence compared with surgery.

  • Structure of the video: This segment covers the first five methods (gentler options). A later segment will cover more radical approaches (laser technologies and laparoscopy).

Method-by-method: pros, cons, and key concepts (first five methods)

1) Permanent/long-term prostatic stent (example: “Mi-Macat” spiral stent)

Concept

  • A spiral stent made from nitinol (nickel-titanium shape-memory alloy) is implanted to keep the urethral passage open.
  • It can be positioned in the prostate/urethra (and is also described as usable in the ureter).

Pros

  • Potentially non-surgical and bloodless.
  • Can restore urine flow by expanding the narrowed passage.

Cons / limitations

  • Stent migration (shift): If the stent moves away from its intended location, the intended effect can be lost.

  • Constant pressure on tissue: Ongoing pressure may disrupt microcirculation, leading to pressure sores, then infection and scarring.

  • Encrustation: Salt/stone buildup can:

    • block the stent (stop working), and
    • make removal difficult.

Bottom line

  • Promising, but real-world drawbacks limit its widespread use.

2) Temporary nitinol stents (example: “Mika-Atin” stents)

Concept

  • Similar shape-memory stent material, implanted temporarily (average duration stated: ~5 days).
  • Intended to expand the urinary passage lumen.

Pros

  • Minimally invasive.
  • Can provide a temporary improvement in urinary flow.

Cons / limitations

  • Does not reduce prostate size: It mainly “pushes apart” the lumen temporarily.

  • Short-lived benefit: Symptoms relief tends to be brief.

  • Positioned as palliative care, especially when:

    • an operation is not possible (for example, due to health constraints).

Bottom line

  • Useful for selected patients, but not ideal as a universal long-term solution.

3) Prostatic urethral “lift” / retractor implant (called “Ralif” in subtitle text)

Concept

  • A permanent implant placed like a “retractor” analogy:
    • “stitches through” prostate thickness
    • creates/increases the urethral lumen channel.

Pros

  • Preserves ejaculation: No retrograde ejaculation; semen exits normally.

  • Can improve “descent/quality” (interpreted as sexual function-related quality).

  • Minimally invasive.
  • Can be performed transurethrally.
  • Notes possible subsequent procedures if needed (e.g., Aquablation after revision/assessment).

Cons / limitations

  • Size limitation: Indicated only for prostates up to ~70 cm³.

  • Often temporary effect: Average duration stated: ~3 years.

  • Reason: The adenoma remains and can continue growing, eventually overgrowing/pressing on the implant—leading to symptom return and possible re-intervention.

Bottom line

  • Effective for selected prostate sizes and patients prioritizing sexual function, but not definitive shrinkage.

4) Water vapor ablation / vapor thermoablation

Concept

  • Minimally invasive access through the urethra (no incisions or direct punctures through urine).
  • A needle is used to deliver high-temperature water vapor into the prostate.
  • This causes tissue necrosis/cell death in adenoma tissue, reducing effective volume and improving symptoms.

Pros

  • Bloodless: no direct cutting/removal of adenoma tissue.
  • Preserves ejaculation and erectile function (as claimed by the speaker).
  • Potentially outpatient.
  • Less need for deep anesthesia.
  • Execution time stated: ~10–15 minutes.
  • Symptoms can decrease and urine flow improves.

Cons / limitations

  • Volume limitation: Mentioned as needing a more “methodical” approach (specific criteria not fully clarified).

  • Delayed effect: Adenoma volume does not shrink immediately. Time to effect: ~3 weeks to 3 months.

  • Non-radical → relapse risk remains: Remaining tissue may regrow.

  • Evidence mentioned:

    • A 2022 study on re-intervention/re-operation after initial results: ~47%. The speaker notes this is a minority overall and interprets that most patients still do better, while emphasizing that long-term outcomes beyond early years (method used ~5 years) are still being established.

Bottom line

  • Good minimally invasive option, but results are not immediate, and recurrence remains possible.

5) Prostatic embolization (arterial method)

Concept

  • Performed under local anesthesia, commonly via the femoral artery.
  • Feeding arteries are visualized using contrast.
  • Microspheres (micro-EMs) are placed into arteries supplying the prostate.
  • Blood supply is blocked → prostate tissue becomes ischemic → atrophy and size reduction.
  • The bladder neck is not targeted, and adenoma tissue is not directly removed.

Pros

  • No general anesthesia required (local anesthesia).
  • Works for any prostate size (as claimed by the speaker).
  • Preserves ejaculation, because the bladder neck is not affected.
  • Improves urination by reducing prostate size.

Cons / limitations

  • Complication risks (from literature):
    • microsphere thrombosis could impair nearby structures (e.g., bladder wall, penis, rectum).
  • Speaker’s quantified risk:
    • serious complications described as about ~1–4%.
  • Possible temporary side effects:
    • perineal pain
    • burning/discomfort when urinating
    • urethral discomfort
  • Non-radical → recurrence possibility remains (adenoma not removed).
  • Evidence mentioned:
    • Two publications (2014–2018 timeframe referenced in subtitles) suggest ~9–20% of patients needed repeat surgical treatment within the first 2 years (example given: TURP).
  • Also discussed as suitable for seriously ill patients who can’t tolerate surgery (palliative role).

Bottom line

  • Strong minimally invasive approach with broad applicability, but not a “cure-all” due to recurrence risk and non-radical nature.

Overall comparison / concluding points

  • The speaker frames these five methods as gentler alternatives to surgery:
    • often aiming to preserve sexual function,
    • but frequently being temporary or non-radical, meaning re-intervention/relapse remains possible.
  • The next part of the series will cover more radical options, including laser technologies and laparoscopy, with comparisons such as enucleation vs laser vaporization.

Speakers / sources featured

  • Igor Matyukhov — urologist, Candidate of Medical Sciences (main speaker).
  • Referenced research / studies (no specific authors named in subtitles):
    • A 2022 study about re-intervention/re-operation after water vapor ablation.
    • Two publications from 2014–2018 about recurrence/re-intervention rates after prostatic embolization.
  • Mentioned historical/clinical experience:
    • The speaker references a 2009 event involving removal of a “Mi-Macat” stent after migration (no additional sources named).

Original video